{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T11:03:22Z","timestamp":1779793402350,"version":"3.53.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,26]]},"DOI":"10.7759\/cureus.109666","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T10:18:49Z","timestamp":1779790729000},"source":"Crossref","is-referenced-by-count":0,"title":["Primary Sj\u00f6gren\u2019s Syndrome Revealed During the Evaluation of Paroxysmal Tonic Spasms Leading to the Diagnosis of Seronegative Neuromyelitis Optica Spectrum Disorder: A Case Report"],"prefix":"10.7759","author":[{"given":"Hajar","family":"Hanane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakaria","family":"Salimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AbdelHamid","family":"Naitlhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moulay Berkchi","family":"Jihad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lahsen","family":"Achemlal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2011.12.006","article-title":"Classification criteria for Sjogren's syndrome: a critical review","volume":"39","author":"Baldini C","year":"2012","unstructured":"Baldini C, Talarico R, Tzioufas AG, Bombardieri S. Classification criteria for Sjogren's syndrome: a critical review. J Autoimmun. 2012, 39:9-14. 10.1016\/j.jaut.2011.12.006","journal-title":"J Autoimmun"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk DM","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, et al.. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015, 85:177-89. 10.1212\/WNL.0000000000001729","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ensci.2023.100443","article-title":"Paroxysmal painful tonic spasms in neuromyelitis optica spectrum disorder","volume":"30","author":"Lucas S","year":"2023","unstructured":"Lucas S, Lalive PH, Lascano AM. Paroxysmal painful tonic spasms in neuromyelitis optica spectrum disorder. eNeurologicalSci. 2023, 30:100443. 10.1016\/j.ensci.2023.100443","journal-title":"eNeurologicalSci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.21.5.656","article-title":"Labial salivary gland biopsy in Sj\u00f6gren's disease","volume":"21","author":"Chisholm DM","year":"1968","unstructured":"Chisholm DM, Mason DK. Labial salivary gland biopsy in Sj\u00f6gren's disease. J Clin Pathol. 1968, 21:656-60. 10.1136\/jcp.21.5.656","journal-title":"J Clin Pathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/art.39859","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren's syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski CH","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, et al.. 2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren's syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol. 2017, 69:35-45. 10.1002\/art.39859","journal-title":"Arthritis Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS)","volume":"33","author":"Kurtzke JF","year":"1983","unstructured":"Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology. 1983, 33:1444-52. 10.1212\/wnl.33.11.1444","journal-title":"Neurology"},{"key":"ref7","article-title":"Aids to the Examination of the Peripheral Nervous System (Memorandum No. 45)","author":"Medical Research Council","year":"1975","unstructured":"Medical Research Council. Aids to the Examination of the Peripheral Nervous System (Memorandum No. 45). Her Majesty's Stationery Office, London, UK; 1975."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/ptj\/67.2.206","article-title":"Interrater reliability of a modified Ashworth scale of muscle spasticity","volume":"67","author":"Bohannon RW","year":"1987","unstructured":"Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther. 1987, 67:206-7. 10.1093\/ptj\/67.2.206","journal-title":"Phys Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.26138","article-title":"Neuromyelitis optica spectrum disorder and autoimmune rheumatological diseases: a report of two cases and literature review","volume":"14","author":"Faisal M","year":"2022","unstructured":"Faisal M, Matarneh A, Alshahwani I, Al-Allaf O, Al-Allaf AW. Neuromyelitis optica spectrum disorder and autoimmune rheumatological diseases: a report of two cases and literature review. Cureus. 2022, 14:e26138. 10.7759\/cureus.26138","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon VA","year":"2005","unstructured":"Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005, 202:473-7. 10.1084\/jem.20050304","journal-title":"J Exp Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0717-1","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin","volume":"13","author":"Jarius S","year":"2016","unstructured":"Jarius S, Ruprecht K, Kleiter I, et al.. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin. J Neuroinflammation. 2016, 13:279. 10.1186\/s12974-016-0717-1","journal-title":"J Neuroinflammation"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001367","article-title":"MRI characteristics of neuromyelitis optica spectrum disorder: an international update","volume":"84","author":"Kim HJ","year":"2015","unstructured":"Kim HJ, Paul F, Lana-Peixoto MA, et al.. MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology. 2015, 84:1165-73. 10.1212\/WNL.0000000000001367","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon VA","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ, et al.. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004, 364:2106-12. 10.1016\/S0140-6736(04)17551-X","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20770","article-title":"Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis","volume":"59","author":"Weinshenker BG","year":"2006","unstructured":"Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF, Lennon VA. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol. 2006, 59:566-9. 10.1002\/ana.20770","journal-title":"Ann Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11634-0","article-title":"Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD)\u00a0- revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: diagnosis and differential diagnosis","volume":"270","author":"Jarius S","year":"2023","unstructured":"Jarius S, Aktas O, Ayzenberg I, et al.. Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD)\u00a0- revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: diagnosis and differential diagnosis. J Neurol. 2023, 270:3341-68. 10.1007\/s00415-023-11634-0","journal-title":"J Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/491985-primary-sjgrens-syndrome-revealed-during-the-evaluation-of-paroxysmal-tonic-spasms-leading-to-the-diagnosis-of-seronegative-neuromyelitis-optica-spectrum-disorder-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T10:18:50Z","timestamp":1779790730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/491985-primary-sjgrens-syndrome-revealed-during-the-evaluation-of-paroxysmal-tonic-spasms-leading-to-the-diagnosis-of-seronegative-neuromyelitis-optica-spectrum-disorder-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.109666","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,26]]}}}